Abstract:Background: Several studies have suggested a role for the gut microbiome and cytokines in atherosclerosis development, but combined analyses of the changes of the gut microbiota and cytokines have not been explored previously. Methods: We treated ApoE-/- and wild-type mice with a high-fat diet for 12 weeks. The gut microbiome and cytokine composition were analyzed using 16S ribosomal DNA sequencing and RayBio Quantibody Arrays, respectively. GO and KEGG analysis were performed to rationalize the potential mechanisms involved in the process of atherosclerosis. Results: Gut bacterial characteristics in ApoE-/- mice were clearly separated and 21 gut bacterial clades were detected by the LEfSe analysis showing significant differences during the development of atherosclerosis. The relative abundance of Verrucomicrobia, Bacteroidaceae, Bacteroides, and Akkermansia showed significant positive correlations with serum total cholesterol, triglyceride (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL). Additionally, the relative abundance of Ruminococcaceae was positive with the level of HDL and the abundance of Rikenellaceae showed a negative relationship with the level of TG and LDL. Thirteen differentially expressed proteins were identified with P-value < 0.05. CXCL5, FGF2, and E-Selectin were significantly negatively associated with Akkermansia and Verrucomicrobia. Additionally, CXCL5 was significantly negatively correlated with Bacteroides and Bacteroidaceae. Three "cellular component" subcategories, 24 "molecular function" subcategories, 752 "biological process" subcategories and 29 statistically remarkable KEGG pathway categories were identified. Conclusions: Gut microbiota changes of the mice having atherosclerosis and their relationship with the inflammatory status could be one of the major etiological mechanisms underlying atherosclerosis.

Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)

The Gut Microbiota-Artery Axis: A Bridge Between Dietary Lipids and Atherosclerosis?

The Gut Microbiome in Atherosclerotic Cardiovascular Disease.

Intestinal Insights: The Gut Microbiome's Role in Atherosclerotic Disease: A Narrative Review

Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis

Intestinal Immunity and Gut Microbiota in Atherogenesis

The Interplay of Microbiome Dysbiosis and Cardiovascular Disease

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism

Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease

Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?

Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential

Gut Microbiota And Atherosclerosis-Focusing On The Plaque Stability

The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review

Human Gut Microbiota in Cardiovascular Disease

Probiotic Enterococcus Faecium Attenuated Atherosclerosis by Improving SCFAs Associated with Gut Microbiota in ApoE-/- Mice

The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis

Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)

The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases

Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease